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Despite lhe critical role of the Langcrhans cells in lhe induction of contact hypersensitivity
reactions, non-Langerhans aniigen-presentirg celis in already sensitized individuals may play a
role in the elicilalion phase of a contact hypersensilivity reaction. Following epictitaneous
challenge with antigens, lhe number of CDl ' DR ' epidermal Langerhans cells increased in a
time-dependent way and. concomiiantly. CDl "OKM5 ' DR ' epidermal non-Langerhans celis
appeared. In parallel with this, the capacity of epidermal cells to preseni both alloantigens and
auto/nominal aniigens increased, and 4 days after initiation of the contact hypersensitivity
reactions 33 53'^J of the epidermal aniigen-prescnting capacity was due to CDi non-
Langerhans antigen-presenting ceils. Thus, contact hypersensitivity skin reactions are accompa-
nied by the appearance of non-Langeriians antigen-presenting cells capable of presenting both
alloantigens and auto/nominai antigens.
Ole Baadsgaard. MD. University of Copenhagen, Deparimcni oJ Dermatology. Ceniofte Ho.\pital.
DK-2900 Hi'llerup, Denmark
In normal human epidermis the Langerhans cell
is the only cell type capable of presenting antigens
to T lymphocytes, thus eliciting T-ce!l activation
[7. 8, 29]. Human epidermal Langerhans cells
express CDl [12] and major liisiocompatibility
complex (MHC) class II molecules [16. 22]. Tlic
Langerhans cells are critical for lhe induction of
delayed-type hypersensilivity reactions in mice
[21. 31, 32]. Thus, sensitizalion through murine
skin depleted of Langerhans cells results in the
induction of antigen-specific tolerance rather
than a contact hypersensitivity reaction [24. 30.
31. 32], While the Langerhans cells are critical for
the induction ofthe immune response in contact
hypersensitivity reactions. non-Langerhans anti-
gen-presenting cells may play a role in the effector
phase ofthe Immune response. This is supported
by the findings in sensitized humans which
demonstrate that irradiation of the skin with up
lo four minimal erythema doses |MED) of UVB.
a dose that normally efliciently abrogates the
function of epidermal Langerhans cells, had no
effect on subscqueni challenge with contact aller-
gens [27]. This coLild be the result of rapid
recovery of functional Langcrhans cell activity.
However, since UVB irradiation induces the
appearance of CDl DR • epidermal non-Lan-
gerhans cells [1-3. 5. 10. 11], this cell type may, in
addition to the Langerhans cells, be capable of
presenting antigens to primed T cells, eliciting T-
cell activation. This observation prompted us to
study the function and type of epidermal antigen-
presenting cells present in the skin al various time
points following initiation of allergic skin reac-
tions. It was found ihat CDI OKM5'DR^
epidermal non-Langerhans antigen-presenting
cells appear during hypersensitivity reactions and
were in two experiments responsible for up to .13
and SV'A, ofthe tola! epidermal antigen-present-
ing capacity. Whether these cells function to up-
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or down-regulate the immune function response
is unknown.
MATERIALS AND METHODS
Pativni.s. Nine paticnis with contact allergy verified
by patch test participated in the study after giving
informed consent. Each patient was challenged with
serial dilutiotis of relevant haplen in order to determine
a concentration of hapten which induced erthetna and
infiltration but not vesiculation (i.e, -I- to -̂  -I- reac-
tions). The haptens used were primin. nickel sulphate,
sodium dichromate. cthylene diaminedihydrochioride,
yarrow, and clioqtjinoi. Twelve-millimetre Finn
chambers were used Tor patch testing. Four patches
with haptens in petrolatum were applied on the volar
forearmat least 5cmapart. at I. .1.4. and 7 days prior to
investigation. In addition, a chamber filled with petrola-
tum was used as vehicle control and applied for 48 h 4
days prior to the study. All patches were removed after
24 or 48 h.
Preparation of epidermal eell .••u.spen.sions. Suction
blister-derived epidermal cells were obtained from
unchallenged areas and Trom siies challenged with
vehicle (petrolatum) or hapten in petrolatum. Epider-
mal sheets were floated deniiiil side down on 0.25%
trypsin (U,S. Biochemical Corp,, Cleveland. Ohio,
USA) in Dulbecco's phosphate-buffered saline (PBS)
for 40 miti al 37 C. Trypsinized epidermal sheets were
transferred to 0.025'Wi DNAse (Sigma. St Louis. Mo,,
USA) in Dulbecco's PBS, teased into a cell suspension,
and were filtered through nylon gauze to achieve a
singie-cell suspension. Fetal bovine serum (FBS) was
added to inactivate the Irypsin, and the eells were
washed three times in PBS containing 10'̂ ., FBS.
Epidermal cells were then resuspended in RPMI 1640
wilh added antibiotics, glutamine. and 10"" human AB
serum from non-transfused male donors. Cell viability
(trypan blue exclusion) was monitored in haemocyto-
meters and was more than ^5"^,..
Epidermal eetl'surfatc membrane slaining. Cell sus-
pensions were stained simultaneously with biotin-con-
jugated anti-HLA-DR (Becton Dickinson. Sunnyvale,
Calif,. USA) and either fluorescein isothiocyanate
(FITC)-conjugated anti-HLet (CD45) (Becton Dickin-
son), OKr6 (CDl), OKM5 (Ortho Immunodiagnos-
tics. Ruritan, NJ, USA), or the appropriate isotype
controls for 45 min at 4 C, The cells were then washed
three times in Dulbecco's PBS containing NaNi and
bovine serum albumin (BSA), and incubated with
streptavidin-conjugated Texas red (Bethesda Research
Ubs . Bethesda. Md. USA) for .̂ 0 mm at 4 C, The cells
were washed, and propidium iodide was added to
monitor viability. A total of \0i)0 ceils was counted
using a Zeiss microscope equipped wilh epifluores-
cence. The resull was expressed as the percenlage
±SEM of labelled viable cells (negative for propidium
iodide) oT total cell count, A three-step staining pro-
cedure was then applied, as previously described |2lj.
The eel! suspensions were briefly incubated with uncon-
jugated monoclonal antibody for 45 min at 4 C, A
second incubation was performed using human serum-
absorbed rhodamine-conjugated rabbit anli-mouse
IgG (Dacopalts. Copenhagen. Denmark) diluted in
PBS containing 10% vol/vot human AB serum. Finally,
a third incubation was perfonned using normal mouse
sera (in excess to occupy residual anti-IgG sites) and
FITC-conjugated monoclonal antibody.
Depletion oJ leucocytes contained within lhe epidermal
cell su.spension. Leucocytes were depleted from the
epidermal cell suspensions using magnetic beads coated
with anti-mouse IgG (Dynal As. Skoyen, Norway).
Epidermal cells pretrealed with anti-HLA-DR. anti-
Leu6 (Becton Dickinson), or a combination ofthe two
antibodies were incubated for .10 min at 4 C. on a
rotating rack; cells bound to beads were removed by
exposure to a magnet, and lhe cell subsets remaining in
suspension were harvested.
Preparation of peripheral hlood mononucleur cells.
Allogeneic or autologous peripheral blood mono-
nuelear cells (MNC) were isolated from heparinized
venous blood by Ficoll Hypaque density-gradient een-
trifugation, MNC al the interface were collected.
washed three times, and restispended in RPMI 1640
with added antibiotics, glutamine. and lO"';, htmian AB
serum,
isolation of T celh. Human peripheral blood MNC
were incubated on plastic for I h at 37 C. The
maerophage-depleted non-phislic adherent MNC were
then rosetted with I"/.. 2-aniinoethyl-isothiouronium
bromide hydro bromide-trealed sheep red blood eells. A
second Ficoll Hypaquedensity-gradientcentrifugation
was performed to obtain non-rosetting B and null cells
at the interface (E ) and rosetted T lymphocytes from
the pellet (E ' ) . The E ' -ceil fraeiion contained more
than 95"ii T lymphocytes as determined by staining wilh
fluoresceinated anti-Leu 1 (CD.*)) (Beeton Dickinson.
Mountain View. Calif.. USA). Tbe Tcells were further
depleted of antigen-presenting ceils by complement lysis
of HLA-DR' leucocytes.
Proliferalive response of T lymphocytes lo alhgeneie
or auiologous epidermal cells. Allogeneie or auiologous
epidermal cell-lymphocyte in vitro reactions were per-
formed in round-botlomed mierotitre wells in 0.2 m!
RPMI 1640 supplemented with W'.- AB serum, gluta-
mine. penicillin, and streptomycin. Various numbers of
gamma-irradiated (2000 rad) epidermal ceils were
added to 50,(HH) or lOO.O(K) responder allogeneic MNC
or autologous T eells. The cultures were pulsed after 6
days wilb i ;(Ci of(-H]TdR per well,harvested I8hlater
on a Nune cell harvester (Tccknunc. Roskilde. Den-
mark), and ['H| TdR incorporation was measured using
a liquid scintillation counter,
Slaiislical analysis. Repeated-measures analyses of
variance was used for statistical evaluation of the
number of antigen-presenting cells. Student's /-test was
used for evaluation of the |'H]TdR uptake by stimu-
lated T cells.
RESULTS
Epidermal celts from contact hypersensitivity
reactions contain increased number.^ of
CDl ^ DR* iton-Langerhans cells atul
CDl 0KM5' DR' non-Langerhans cells
Occlusion of the skin with petrolatum for 48 h










0 1 2 3 4 5 6 7
Days After Challenge
FIG. I. Five patients with veritied allergic contact hypersensitivity
were challenged with hapten 1.3.4. and 7 days prior to investigation.
The number of CDl "̂ DR"* epidermal Langerhans cells and the
number of C)KM5^I)R* epidermal non-Langerhans cells were
determined from haplcn-challenged sites and from a vebicle-
(petrolatum) challenged site (0). In all five patients tested, the
number of Langerhans cells increased in a time-dependent fashion,
and concomitantly non-Langerhans OKM5 ' DR ' epidermal cells
appeared. Results are expressed as mean values of five individuals
+ SEM,
of CDl^DR ' Langerhans cells in the absence of
detectable numbers of CDl DR+ epidermal
cells. Becatjse of this immunostitnulatory effect of
the vehicle (petrolatum occlusion), all test results
wcrccompared with vehicle controls and not with
unchallenged skin. Challenged skin frotn pre-
viously sensitized persons demonstrated an
increased number of potential epidermal antigen-
presenting cells in 5 out of 5 individuals tested
(n = 5) (P < 0.02). Statistical significance was seen
already at day 3. The number of C D P D R ^
Langcrhans cells and CDl DR'/OKM5*DR^
non-Langerhans epidermal cells was assessed in
each individual following vehicle control and 1.3.
4, and 7 days after challenge. The number of
CDl ' DR ' Langerhans cells increased in a time-
dependent fashion in all individuals tested from
day I {tnean 2,2±0.067i.. n = 5) to a maximum at
day 7 (mean 3.7± 1.4%. /i = 5). Concomitantly,
the number or CDl DR ' /OKM5'DR^ non-
Langerhans epidermal cells also increased from
the vehicle control baseline (mean 0%-l-0, n = 5)
to a maximum at day 7 (mean 1.3+0.6%, n = 5)
(Fig. 1). The number of CDI DR' epidermal
cells was equal to the number of O K M 5 ' D R '
epidermal cells, and both the OKM5 ' epidermal
cells and the DR' epidermal cells coexpressed
HLel. indicating that all CDl DRV
R*̂  epidermal cells were bone marrow-
derived leucocytes and that no DR' or OKM5*
keratinocytes were present. These data also indi-
cate that CD1"DR' epidermal cells coexpress
OKM5. Furthermore, only a minority (35 + 2%,
n^2) of the OKM5' epidermal cells co-
expressed OKM I. indicating that the majority
of the OK.M5 DR' epidermal ceils are
OKM1-OKM5^
Epidermal cells from contact hyper.sensitivity
reaction.^ demonstrate increa.^ed capacity to
stimulate autologous T cells
In order to determine whether the Increased
number ofLangerhans cells and non-Langerhans
CDl OKM5 • DR + epidermal cells resulted in an
enhanced capacity of epidermal cells to activate
autologous T cells, epidermal cell lymphocyte
reactions were performed. Increasing numbers of
epidermal cells from a petrolatum-challenged
area and from sites challenged with haplen I, 3,4,
and 7 days before were added to antigen-present-
ing cell-depleted autoiogous T cells. At all epider-
mal cell concentrations tested from 10,000 to
160.000, primin- (0.0r'/;> in petrolatum) chal-
lenged epidermal cells demonstrated a time-
dependent increase in the capacity to activate
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FIG. 2. Epidermal cells in suspension were obtained from potrotalum-
challenged skin (0) and from skin challenged with hapten I. 3. 4. and 7
days prior lo investigation. One hundred thousand autologous T celts
were stimulated with I().(KH) (suboptimiil number) und 80.000 (optimal
number) gamma-irradiated epidcnn;tl ceils, and the resulting T-cell
proliferation was measured as [M4]TdR incorporation. Results are
expressed as mean cpm + SEM of triplicate wells from a representative
experiment.
autologous T cells (F"ig. 2.). Similar results were
obtained in another patient using nickel sulphate.
Results from the patient challenged with nickel
sulphate on day 4 are shown in Fig. 5.
Contact hypersensitivity reactions result in an
increased capacity of epidermal cells to activate
allogeneic T cells
The increased capacity of hapten-challenged
epidermal cells to activate autoiogous T cells
could be the result ofeither an increased number
of antigen-presenting cells or increasing presen-
tation of processed haplen to the primed autolo-
gous Tcells. To determine whether the challenged
skin actually demonstrated an increased func-
tional antigen-presenting eapaeity, allogeneic
epidermal cell lymphoeyte reactions were per-
formed since this reaction is not affected by the
presence of nominal antigen.
Hapten-challenged epidermal cells in 5 out of 5
individuals tested demonstrated enhanced capa-
city to activate allogeneic T cells relative to
vehicle-challenged epidermal cells (Table 1 and
Fig, 3). The mean percentage increases compared
with vehicle-challenged control values at an epi-
dermal cell concentration of 40,000 is shown in
Table I (n = 5, P<0,05, Student's t test). The
increase was seen in all patients tested indepen-
TABLE I, The percentage increase in ['H]TdR uptake by
allogcneic MNC stimulated with hapten-challenged
skin relative lo MNC stimulaled with vehicle-chal-
lenged controi skin 4 and 7 days after challenge in Hve
different patients



















dent of the hapten used. However, the increase
was less than when autologous T cells were used
as responder cells. Furthermore, the allogeneic
reaction peaked at day 3, whereas the autologous
reaction was still increasing 7 days after hapten
challenge.
Irrespective of these differences, hapten-chal-
lenged skin demonstrated increased capacity to
present not only nominal and/or autoantigens
but also alloantigens, and thus an increased
function of antigen-presenting cells.
o













FIG, 3. Epidermal cells in suspension were obtained from petrolalum-
ehatlenged skin (0) and from skin challenged with hupten I. y. 4. and 7
days prior to investigation. Ten thousand (suboplimal number) and
SO.OOO (optimal number) gamma-irradiated epidermal ceils were added to
30.000 aliogeneic MNC, and Ihe resulting T-ceil proliferation was
measured as {'HJTdR incorporation. Results are expressed as mean

















4. Med la +0R
Fici. 4. Stimulation of 50.000 allogeneic MNC by 40,(X)0 unchallenged epidermal cells
(C-EC). vehicle-chailenged epidermal cells (OC-ECJ. or hapten-challenged epidermal
cells (AC-EC). The epidernKil cells were treated with (1) magnetic beads-I-media alone
(-I-B-I-media): (2) anii-HLA-DR and magnetic beads (-l-B-i-DR); aitd (3) Leu6 and
magnetic beads ( + B + Leu6). Data are expressed as mean cpm ±SEM of triplicate wells
from a representative experimeni.
The capacity of attergen-chattenged skin to
activate T cetts is dependent on both CDl' DR^
Langerhans cells and CDl DR* antigen-
presenting cells
The discovery of the presence of non-Langer-
hans DR' epidermal cells in hypersensitivity
reactions raises the possibility that non-Langer-
hans antigen-presenting cells may participate in
the epidermal antigen presentation during an
allergic skin reaction. To assess the functional
antigen-presenting capacity of the non-Langer-
hans epidermal cells at day 4. we removed cells
expressing CDl {CDPDR^ Langerhans cells)
by incubation with Leu6 antibody plus Dyna-
beads. or ceils expressing DR (CDl '^DR * Lan-
gerhans cells and CDl DR' non-Langerhans
epidermal cells) by incubation with anti-HLA-
DR plus Dynabeads. This decreased the number
of CDl ^ or DR ' epidermal cells to undetectable
levels. Depletion of CDl HCDl^DR-^ Langer-
hans cells) resulted in only partial abrogation of


































FIG. 5. Stimulation of 100.000 aulologous T cells by 40,00(1 tjnchalleiiged epidermal cells
(C-EC), vehicle-challenged epidermal eells (OC-EC). or hapten-challenged epidermal
cells (AC-EC). The epidermal cells were treated witli (1) magnetic heads (-t-B-hmedia);
(2) anti-HLA*DR and magnetic heads {-(-B + DR); and (3) Leti6 and magnetic beads
(-}-B-fLeu6). Data are expressed as mean cpmfSFM of triplicate wells from a
representative experimeni.
the epidermal antigen presentation capacity. In
contrast, depletion of all DR' epidermal cells
resulted in total abrogation of the epidermal
alloantigen presentation capacity (AC-EC) (Fig.
4). This was not the result of incomplete removal
of C D P cells since depletion of CDl ^ eells
contained within unchallenged (C-EC) or vehicle-
challenged (OC-EC) epidermal cells totally abro-
gated the epidermal antigen-presenting function
(Fig. 4). Similar results were obtained when
autologous responder T cells were used, indicat-
ing that CDl D R ' non-Langerhans antigen-
presenting cells can present hoth alloantigens and
autologous/nominal antigetis (Fig. 5). In two
experiments 33 and 5yA, of the total antigen-
presenting cell activity of 40.000 epidermal cells
was provided by non-Langerhans antigen-pre-
senting cells (Fig. 4).
DISCUSSION
The Langerhans cell is the only known atitigen-
presenting cell in normal human epldertnis, and
its role as an antigen-processing cell in the
induetion of positive itnmune responses to unti-
gen introduced through the skin is well estab-
lished [14, 21. 31, 32]. However, the epidermal
cellular sources for antigen presentation in the
induction phase of allergic contact dermatitis
reactions are less clear. Irradiation of sensitized
individuals in vivo with a single dose of UVB
radiation sufficient to abrograte lhe function of
Langerhans cells did not change the immune
reactivity oTthe skin to subsequent ctiallenge with
antigen [27]. This eould be explained by rapid
recovery of epidermal Langerhans cells following
the irradiation. However, normally more than I
week is needed for recovery of epidermal Langer-
hans eells following in vivo UVB exposure [10].
Therefore, although the Langerhans eell is the
critical antigen-presenting cell in the sensitization
phase of the contact hypersensitivity response,
epidermal non-Langerhans antigen-presenting
cells could, in addition to Langerhans cells, play a
role in the induction phase. In accordance with
others we found an increased number of epider-
mal Langerhans cells following the contact
hypersensitivity reactions [9. 13]. However, in
addition to the increased number of Langerhans
cells, a non-Langerhans antigen-presenting cell
subtype appeared. These cells were distinct from
the Langerhans cells in that they were smaller,
non-dendritic, and they lacked the CDl determi-
nant and expressed the blood monocyte antigen
defined by the monocional antibody OKM5. The
majority ofthe OKM5' epidermal ceils lacked
expression of OKMl and therefore are analo-
gous to 11 minor subpopulation (<5'X,) of
OKMl 0 K M 5 ' blood monocytes which are
uniquely capable of activating autoreactive im-
munoregulalory Tcells [25] which may be impor-
tant for down-regulation of imtnunc responses
[15, 20. 23, 28]. All CDI
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R+ epidermal cells expressed thecom-
tnon leucocyte antigen. CD45, demonstrating
their bone marrow origin. Keratinocytes in aller-
gic skin reactions can express both HLA-DR and
OKM.'i [19.26, 33]. These molecules are probably
induced by gamma interferon and other lym-
phokines released from local activated T cells [6],
We did not detect any HLel DR • or
HLel " 0 K M 5 ' epidermal cells. This is probably
because of the weak hypersensitivity reaction
induced and the consequently minimal T-cell
infiltration and lymphokine release,
Concomitantly with the increase in number of
CD1^DR+ Langerhans cells and CDl DR +
epidermal cells there was an inerease in the
antigen-presenting capacity of hapten-challenged
epidertnal cells. Thi.s enhanced capacity could
result from either the increased number of Lan-
gerhans cells, the increased number of non-
Langerhans cell DR* epidermal cells, or both. In
order to determine the relative contribution ofthc
two diHercnt types of DR' epidermal cells.CDI •
or DR ' epidermal cells were depleted from the
stimulator population prior lo culture with T
cells. Depletion of C D P cells (CDI ' DR • Lan-
gerhans cells) from unchallenged or petrolatum-
challenged epidermal cells totally abrogated the
antigen-presenting cell function. In contrast, de-
pletion of autologous C D P epidermal cells
obtained 4 days after challenge wilh hapten only
decreased the antigen-presenting cell function by
77and47"'i] in two different patients. Depletion of
DR' epidermal cells ( C D r D R ' Langerhans
cells and CDI DR' epidermal cells) totally
abrogated T-cell activation. Thus, at day 4. 33 or
53"'ii of the capacity of epidermal cells to activate
T cells may be provided by non-Langerhans
antigen-presenting cells.
The function ofthe heterogeneous population
of CDl DR ' non-Langerhans antigen-present-
ing cells in contact hypersensitivity skin reactions
and irritant reactions [18] is unknown. They may
function to enhance the ongoing immune re-
sponse by presenting nominal antigen to primed
T cells. However, they may also be analogous to
the CDl OKM5'DR antigen-presenting cell
subtype that appears in human skin in response to
certain wavelengths of UV irradiation [I. 2. 3. 5.
10, 11]. This UV-induced antigen-presenting cell
population activates suppressor T-cell pathways
and tnay function to down-regtilate immune
responses [2, 4]. Thus, the non-Langerhans anti-
gen-presenting cells may represent a negative
feedback mechanism down-regulating the inflam-
matory reaction in contact denrtatitis.
Whether these non-Langerhans cells belong to
the monocyte or Langerhans cell lineage is
unknown. In cutaneous T-cell lymphoma
CDl O K M 5 ' D R ' non-Langerhans cells are
present in the epidermis. However, these cells lack
Birbeck granules [17]. Thus, the C D | - O K M 5 '
epidermal cells may be precursors to Langerhans
ceils and in the epidermal environment they may
lose their OKM5 expression and gain CDI and
Birbeck granules. However, they may also be
distinct from the Langerhans cell lineage.
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